EMEA (Europe, Middle East and Africa) Botanical and Plant-Derived Drugs Market Report 2017

October 2017 | 126 pages | ID: E1A156F886FPEN
QYResearch

Abstracts

In this report, the EMEA Botanical and Plant-Derived Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Botanical and Plant-Derived Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Botanical and Plant-Derived Drugs market competition by top manufacturers/players, with Botanical and Plant-Derived Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Yunnan Baiyao
• Tongrentang
• Tasly
• Sanjiu
• Zhongxin
• Haiyao
• Taiji
• Tsumura
• Schwabe
• Madaus
• Weleda
• Blackmores
• Arkopharma
• Sido Muncul
• Arizona Natural
• Dabur
• Herbal Africa
• Nature's Answer
• Bio-Botanica
• Zand
• Nature Herbs
• Imperial Ginseng
• Kunming Pharma
• JZJT
• Guangzhou Pharma

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Terpenes and Steroids
• Alkaloids and Glycosides
• Phenols
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Botanical and Plant-Derived Drugs for each application, including

• Poultry
• Fisheries
• Fruits and Vegetables
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Botanical and Plant-Derived Drugs Market Report 2017

1 BOTANICAL AND PLANT-DERIVED DRUGS OVERVIEW

1.1 Product Overview and Scope of Botanical and Plant-Derived Drugs
1.2 Classification of Botanical and Plant-Derived Drugs
  1.2.1 EMEA Botanical and Plant-Derived Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Botanical and Plant-Derived Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Terpenes and Steroids
  1.2.4 Alkaloids and Glycosides
  1.2.5 Phenols
  1.2.6 Other
1.3 EMEA Botanical and Plant-Derived Drugs Market by Application/End Users
  1.3.1 EMEA Botanical and Plant-Derived Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Poultry
  1.3.3 Fisheries
  1.3.4 Fruits and Vegetables
  1.3.5 Other
1.4 EMEA Botanical and Plant-Derived Drugs Market by Region
  1.4.1 EMEA Botanical and Plant-Derived Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Botanical and Plant-Derived Drugs (2012-2022)
  1.5.1 EMEA Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Botanical and Plant-Derived Drugs Revenue and Growth Rate (2012-2022)

2 EMEA BOTANICAL AND PLANT-DERIVED DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Botanical and Plant-Derived Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Botanical and Plant-Derived Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Botanical and Plant-Derived Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Botanical and Plant-Derived Drugs Sale Price by Players (2012-2017)
2.2 EMEA Botanical and Plant-Derived Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Botanical and Plant-Derived Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Botanical and Plant-Derived Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Botanical and Plant-Derived Drugs Sale Price by Type (2012-2017)
2.3 EMEA Botanical and Plant-Derived Drugs (Volume) by Application
2.4 EMEA Botanical and Plant-Derived Drugs (Volume and Value) by Region
  2.4.1 EMEA Botanical and Plant-Derived Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Botanical and Plant-Derived Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Botanical and Plant-Derived Drugs Sales Price by Region (2012-2017)

3 EUROPE BOTANICAL AND PLANT-DERIVED DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Botanical and Plant-Derived Drugs Sales and Value (2012-2017)
  3.1.1 Europe Botanical and Plant-Derived Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Botanical and Plant-Derived Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Botanical and Plant-Derived Drugs Sales and Market Share by Type
3.3 Europe Botanical and Plant-Derived Drugs Sales and Market Share by Application
3.4 Europe Botanical and Plant-Derived Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Botanical and Plant-Derived Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Botanical and Plant-Derived Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST BOTANICAL AND PLANT-DERIVED DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Botanical and Plant-Derived Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Botanical and Plant-Derived Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Botanical and Plant-Derived Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Botanical and Plant-Derived Drugs Sales and Market Share by Type
4.3 Middle East Botanical and Plant-Derived Drugs Sales and Market Share by Application
4.4 Middle East Botanical and Plant-Derived Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Botanical and Plant-Derived Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Botanical and Plant-Derived Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)

5 AFRICA BOTANICAL AND PLANT-DERIVED DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Botanical and Plant-Derived Drugs Sales and Value (2012-2017)
  5.1.1 Africa Botanical and Plant-Derived Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Botanical and Plant-Derived Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Botanical and Plant-Derived Drugs Sales and Market Share by Type
5.3 Africa Botanical and Plant-Derived Drugs Sales and Market Share by Application
5.4 Africa Botanical and Plant-Derived Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Botanical and Plant-Derived Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Botanical and Plant-Derived Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Botanical and Plant-Derived Drugs Sales and Growth Rate (2012-2017)

6 EMEA BOTANICAL AND PLANT-DERIVED DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Yunnan Baiyao
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Botanical and Plant-Derived Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Yunnan Baiyao Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Tongrentang
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Botanical and Plant-Derived Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Tongrentang Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Tasly
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Botanical and Plant-Derived Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Tasly Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanjiu
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Botanical and Plant-Derived Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanjiu Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Zhongxin
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Botanical and Plant-Derived Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Zhongxin Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Haiyao
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Botanical and Plant-Derived Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Haiyao Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Taiji
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Botanical and Plant-Derived Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Taiji Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Tsumura
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Botanical and Plant-Derived Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Tsumura Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Schwabe
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Botanical and Plant-Derived Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Schwabe Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Madaus
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Botanical and Plant-Derived Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Madaus Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Weleda
6.12 Blackmores
6.13 Arkopharma
6.14 Sido Muncul
6.15 Arizona Natural
6.16 Dabur
6.17 Herbal Africa
6.18 Nature's Answer
6.19 Bio-Botanica
6.20 Zand
6.21 Nature Herbs
6.22 Imperial Ginseng
6.23 Kunming Pharma
6.24 JZJT
6.25 Guangzhou Pharma

7 BOTANICAL AND PLANT-DERIVED DRUGS MANUFACTURING COST ANALYSIS

7.1 Botanical and Plant-Derived Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Botanical and Plant-Derived Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Botanical and Plant-Derived Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Botanical and Plant-Derived Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA BOTANICAL AND PLANT-DERIVED DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Botanical and Plant-Derived Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Botanical and Plant-Derived Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Botanical and Plant-Derived Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Botanical and Plant-Derived Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Botanical and Plant-Derived Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Botanical and Plant-Derived Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Botanical and Plant-Derived Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Botanical and Plant-Derived Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Botanical and Plant-Derived Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Botanical and Plant-Derived Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Botanical and Plant-Derived Drugs
Figure EMEA Botanical and Plant-Derived Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Botanical and Plant-Derived Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Terpenes and Steroids Product Picture
Figure Alkaloids and Glycosides Product Picture
Figure Phenols Product Picture
Figure Other Product Picture
Figure EMEA Botanical and Plant-Derived Drugs Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Botanical and Plant-Derived Drugs by Application in 2016
Figure Poultry Examples
Table Key Downstream Customer in Poultry
Figure Fisheries Examples
Table Key Downstream Customer in Fisheries
Figure Fruits and Vegetables Examples
Table Key Downstream Customer in Fruits and Vegetables
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Botanical and Plant-Derived Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Botanical and Plant-Derived Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Botanical and Plant-Derived Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Botanical and Plant-Derived Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Botanical and Plant-Derived Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Botanical and Plant-Derived Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Botanical and Plant-Derived Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Botanical and Plant-Derived Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Botanical and Plant-Derived Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Botanical and Plant-Derived Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Sales Share by Players (2012-2017)
Figure 2016 Botanical and Plant-Derived Drugs Sales Share by Players
Figure 2017 Botanical and Plant-Derived Drugs Sales Share by Players
Figure EMEA Botanical and Plant-Derived Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Botanical and Plant-Derived Drugs Revenue Share by Players
Table 2017 EMEA Botanical and Plant-Derived Drugs Revenue Share by Players
Table EMEA Botanical and Plant-Derived Drugs Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Botanical and Plant-Derived Drugs by Type (2012-2017)
Figure EMEA Botanical and Plant-Derived Drugs Sales Market Share by Type (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Botanical and Plant-Derived Drugs by Type in 2016
Table EMEA Botanical and Plant-Derived Drugs Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Botanical and Plant-Derived Drugs by Application (2012-2017)
Figure EMEA Botanical and Plant-Derived Drugs Sales Market Share by Application in 2016
Table EMEA Botanical and Plant-Derived Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Botanical and Plant-Derived Drugs by Region (2012-2017)
Figure EMEA Botanical and Plant-Derived Drugs Sales Market Share in 2016
Table EMEA Botanical and Plant-Derived Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Botanical and Plant-Derived Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Botanical and Plant-Derived Drugs by Region (2012-2017)
Figure EMEA Botanical and Plant-Derived Drugs Revenue Market Share Regions in 2016
Table EMEA Botanical and Plant-Derived Drugs Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Botanical and Plant-Derived Drugs Revenue and Growth Rate (2012-2017)
Table Europe Botanical and Plant-Derived Drugs Sales (K Pcs) by Type (2012-2017)
Table Europe Botanical and Plant-Derived Drugs Market Share by Type (2012-2017)
Figure Europe Botanical and Plant-Derived Drugs Market Share by Type in 2016
Table Europe Botanical and Plant-Derived Drugs Sales (K Pcs) by Application (2012-2017)
Table Europe Botanical and Plant-Derived Drugs Market Share by Application (2012-2017)
Figure Europe Botanical and Plant-Derived Drugs Market Share by Application in 2016
Table Europe Botanical and Plant-Derived Drugs Sales (K Pcs) by Countries (2012-2017)
Table Europe Botanical and Plant-Derived Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Botanical and Plant-Derived Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Botanical and Plant-Derived Drugs Sales Market Share by Countries in 2016
Table Europe Botanical and Plant-Derived Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Botanical and Plant-Derived Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Botanical and Plant-Derived Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Botanical and Plant-Derived Drugs Revenue Market Share by Countries in 2016
Figure Germany Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Botanical and Plant-Derived Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Botanical and Plant-Derived Drugs Sales (K Pcs) by Type (2012-2017)
Table Middle East Botanical and Plant-Derived Drugs Market Share by Type (2012-2017)
Figure Middle East Botanical and Plant-Derived Drugs Market Share by Type (2012-2017)
Table Middle East Botanical and Plant-Derived Drugs Sales (K Pcs) by Applications (2012-2017)
Table Middle East Botanical and Plant-Derived Drugs Market Share by Applications (2012-2017)
Figure Middle East Botanical and Plant-Derived Drugs Sales Market Share by Application in 2016
Table Middle East Botanical and Plant-Derived Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Botanical and Plant-Derived Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Botanical and Plant-Derived Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Botanical and Plant-Derived Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Botanical and Plant-Derived Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Botanical and Plant-Derived Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Botanical and Plant-Derived Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Botanical and Plant-Derived Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Botanical and Plant-Derived Drugs Sales (K Pcs) by Type (2012-2017)
Table Africa Botanical and Plant-Derived Drugs Sales Market Share by Type (2012-2017)
Figure Africa Botanical and Plant-Derived Drugs Sales Market Share by Type (2012-2017)
Figure Africa Botanical and Plant-Derived Drugs Sales Market Share by Type in 2016
Table Africa Botanical and Plant-Derived Drugs Sales (K Pcs) by Application (2012-2017)
Table Africa Botanical and Plant-Derived Drugs Sales Market Share by Application (2012-2017)
Figure Africa Botanical and Plant-Derived Drugs Sales Market Share by Application (2012-2017)
Table Africa Botanical and Plant-Derived Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Botanical and Plant-Derived Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Botanical and Plant-Derived Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Botanical and Plant-Derived Drugs Sales Market Share by Countries in 2016
Table Africa Botanical and Plant-Derived Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Botanical and Plant-Derived Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Botanical and Plant-Derived Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Botanical and Plant-Derived Drugs Revenue Market Share by Countries in 2016
Figure South Africa Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Yunnan Baiyao Botanical and Plant-Derived Drugs Basic Information List
Table Yunnan Baiyao Botanical and Plant-Derived Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Yunnan Baiyao Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Yunnan Baiyao Botanical and Plant-Derived Drugs Sales Market Share in EMEA (2012-2017)
Figure Yunnan Baiyao Botanical and Plant-Derived Drugs Revenue Market Share in EMEA (2012-2017)
Table Tongrentang Botanical and Plant-Derived Drugs Basic Information List
Table Tongrentang Botanical and Plant-Derived Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Tongrentang Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Tongrentang Botanical and Plant-Derived Drugs Sales Market Share in EMEA (2012-2017)
Figure Tongrentang Botanical and Plant-Derived Drugs Revenue Market Share in EMEA (2012-2017)
Table Tasly Botanical and Plant-Derived Drugs Basic Information List
Table Tasly Botanical and Plant-Derived Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Tasly Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Tasly Botanical and Plant-Derived Drugs Sales Market Share in EMEA (2012-2017)
Figure Tasly Botanical and Plant-Derived Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanjiu Botanical and Plant-Derived Drugs Basic Information List
Table Sanjiu Botanical and Plant-Derived Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanjiu Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanjiu Botanical and Plant-Derived Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanjiu Botanical and Plant-Derived Drugs Revenue Market Share in EMEA (2012-2017)
Table Zhongxin Botanical and Plant-Derived Drugs Basic Information List
Table Zhongxin Botanical and Plant-Derived Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Zhongxin Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Zhongxin Botanical and Plant-Derived Drugs Sales Market Share in EMEA (2012-2017)
Figure Zhongxin Botanical and Plant-Derived Drugs Revenue Market Share in EMEA (2012-2017)
Table Haiyao Botanical and Plant-Derived Drugs Basic Information List
Table Haiyao Botanical and Plant-Derived Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Haiyao Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Haiyao Botanical and Plant-Derived Drugs Sales Market Share in EMEA (2012-2017)
Figure Haiyao Botanical and Plant-Derived Drugs Revenue Market Share in EMEA (2012-2017)
Table Taiji Botanical and Plant-Derived Drugs Basic Information List
Table Taiji Botanical and Plant-Derived Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Taiji Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiji Botanical and Plant-Derived Drugs Sales Market Share in EMEA (2012-2017)
Figure Taiji Botanical and Plant-Derived Drugs Revenue Market Share in EMEA (2012-2017)
Table Tsumura Botanical and Plant-Derived Drugs Basic Information List
Table Tsumura Botanical and Plant-Derived Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Tsumura Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Tsumura Botanical and Plant-Derived Drugs Sales Market Share in EMEA (2012-2017)
Figure Tsumura Botanical and Plant-Derived Drugs Revenue Market Share in EMEA (2012-2017)
Table Schwabe Botanical and Plant-Derived Drugs Basic Information List
Table Schwabe Botanical and Plant-Derived Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Schwabe Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Schwabe Botanical and Plant-Derived Drugs Sales Market Share in EMEA (2012-2017)
Figure Schwabe Botanical and Plant-Derived Drugs Revenue Market Share in EMEA (2012-2017)
Table Madaus Botanical and Plant-Derived Drugs Basic Information List
Table Madaus Botanical and Plant-Derived Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Madaus Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Madaus Botanical and Plant-Derived Drugs Sales Market Share in EMEA (2012-2017)
Figure Madaus Botanical and Plant-Derived Drugs Revenue Market Share in EMEA (2012-2017)
Table Weleda Botanical and Plant-Derived Drugs Basic Information List
Table Blackmores Botanical and Plant-Derived Drugs Basic Information List
Table Arkopharma Botanical and Plant-Derived Drugs Basic Information List
Table Sido Muncul Botanical and Plant-Derived Drugs Basic Information List
Table Arizona Natural Botanical and Plant-Derived Drugs Basic Information List
Table Dabur Botanical and Plant-Derived Drugs Basic Information List
Table Herbal Africa Botanical and Plant-Derived Drugs Basic Information List
Table Nature's Answer Botanical and Plant-Derived Drugs Basic Information List
Table Bio-Botanica Botanical and Plant-Derived Drugs Basic Information List
Table Zand Botanical and Plant-Derived Drugs Basic Information List
Table Nature Herbs Botanical and Plant-Derived Drugs Basic Information List
Table Imperial Ginseng Botanical and Plant-Derived Drugs Basic Information List
Table Kunming Pharma Botanical and Plant-Derived Drugs Basic Information List
Table JZJT Botanical and Plant-Derived Drugs Basic Information List
Table Guangzhou Pharma Botanical and Plant-Derived Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Botanical and Plant-Derived Drugs
Figure Manufacturing Process Analysis of Botanical and Plant-Derived Drugs
Figure Botanical and Plant-Derived Drugs Industrial Chain Analysis
Table Raw Materials Sources of Botanical and Plant-Derived Drugs Major Manufacturers in 2016
Table Major Buyers of Botanical and Plant-Derived Drugs
Table Distributors/Traders List
Figure EMEA Botanical and Plant-Derived Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Botanical and Plant-Derived Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Botanical and Plant-Derived Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Botanical and Plant-Derived Drugs Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Botanical and Plant-Derived Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Botanical and Plant-Derived Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Botanical and Plant-Derived Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Botanical and Plant-Derived Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Botanical and Plant-Derived Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Botanical and Plant-Derived Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Botanical and Plant-Derived Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Botanical and Plant-Derived Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Botanical and Plant-Derived Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Botanical and Plant-Derived Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Botanical and Plant-Derived Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Botanical and Plant-Derived Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Botanical and Plant-Derived Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Botanical and Plant-Derived Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Botanical and Plant-Derived Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Botanical and Plant-Derived Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Botanical and Plant-Derived Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Botanical and Plant-Derived Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Botanical and Plant-Derived Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources